SEARCH

SEARCH BY CITATION

References

  • 1
    Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M; American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010 Nov; 25(11): 226794.
  • 2
    Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007 Mar; 89: 34953.
  • 3
    Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low-energy femoral fractures associated with the longterm use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf. 2009; 32(9): 77585.
  • 4
    Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?. Injury. 2008 Feb; 39: 22431.
  • 5
    Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008 May–Jun; 22(5): 34650.
  • 6
    Bunning RD, Rentfro RJ, Jelinek JS. Low-energy femoral fractures associated with long-term bisphosphonate use in a rehabilitation setting: a case series. PM&R. 2010 Jan; 2(1): 7680.
  • 7
    Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009 Nov; 91(11): 255661.
  • 8
    Glennon DA. Subtrochanteric stress fractures in six patients on long term bisphosphonate therapy: a case series. Bone. 2009 May; 44 (Suppl 1): S778.
  • 9
    Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res. 2009 Jun; 24(6): 1095102.
  • 10
    Abrahamsen B, Eiken P, Eastell R. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis. J Clin Endocrinol Metab. 2010 Dec; 95(12): 525865.
  • 11
    Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. 2011 Feb 23; 305(8): 7839.
  • 12
    Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res. 2011 May; 26(5): 9931001.
  • 13
    Arneson TJ, Melton LJ 3rd, Lewallen DG, O'Fallon WM. Epidemiology of diaphyseal and distal femoral fractures in Rochester, Minnesota, 1965–1984. Clin Orthop Relat Res. 1988 Sep; 234: 18894.
  • 14
    Bengnér U, Ekbom T, Johnell O, Nilsson BE. Incidence of femoral and tibial shaft fractures. Epidemiology 1950–1983 in Malmö, Sweden. Acta Orthop Scand. 1990; Jun; 61(3): 2514.
  • 15
    Hedlund R, Lindgren U. Epidemiology of diaphyseal femoral fracture. Acta Orthop Scand. 1986 Oct; 57(5): 4237.
  • 16
    Nieves JW, Bilezikian JP, Lane JM, Einhorn TA, Wang Y, Steinbuch M, Cosman F. Fragility fractures of the hip and femur: incidence and patient characteristics. Osteoporos Int. 2010; 21: 299408.
  • 17
    Leung F, Lau T-W, To M, Luk K-K, Kung A. Atypical femoral diaphyseal and subtrochanteric fractures and their association with bisphosphonates. BMJ Case Reports. 2009; bcr10.2008.1073. Mar 5 [Epub ahead of print].
  • 18
    Wang Z, Bhattacharyya T. Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly. 1996–2007. J Bone Miner Res. 2011 Mar; 26(3): 55360.
  • 19
    Maravic M, Taupin P, Landais P, Roux C. Change in hip fracture incidence over the last 6 years in France. Osteoporos Int. 2011 Mar; 22(3): 797801.
  • 20
    Schilcher J, Michaëlsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011 May; 364(18): 172837.
  • 21
    McCullagh P, Nelder JA. Generalized linear models. 2nd ed. London: Chapman and Hall, 1989.
  • 22
    Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA; The IOF CSA Working Group on Fracture Epidemiology. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011 May; 22(5): 127788.
  • 23
    Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int. 2011 Feb; 22(2): 37390.
  • 24
    Giusti A, Hamdy NA, Papapoulos SE. Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies. Bone. 2010 Aug; 47(2): 16980.
  • 25
    Tanaka S, Yoshimura N, Kuroda T, Hosoi T, Saito M, Shiraki M. The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women—A joint analysis of the Nagano, Miyama, and Taiji Cohorts. Bone. 2010 Dec; 47(6): 106470.
  • 26
    Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA. 1987; 257: 14925.
  • 27
    Sato Y, Kanoko T, Satoh K, Iwamoto J. Risk factors for hip fracture among elderly patients with Alzheimer's disease. J Neurol Sci. 2004; 223: 10712.
  • 28
    Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19(4): 38597.
  • 29
    Reid IR. Fat and bone. Arch Biochem Biophys. 2010 Nov 1; 503(1): 207.
  • 30
    Premaor MO, Pilbrow L, Tonkin C, Parker RA, Compston J. Obesity and fractures in postmenopausal women. J Bone Miner Res. 2010; 25(2): 2927.